Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Carlotta, Becherini"'
Autor:
Andrea Lancia, Gianluca Ingrosso, Beatrice Detti, Eleonora Festa, Elisabetta Bonzano, Flavia Linguanti, Federico Camilli, Niccolò Bertini, Salvatore La Mattina, Carolina Orsatti, Giulio Francolini, Elisabetta Maria Abenavoli, Lorenzo Livi, Cynthia Aristei, Dorine de Jong, Karine A. Al Feghali, Shankar Siva, Carlotta Becherini
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The therapeutic landscape of metastatic prostate cancer has undergone a profound revolution in recent years. In addition to the introduction of novel molecules in the clinics, the field has witnessed a tremendous development of functional imaging mod
Externí odkaz:
https://doaj.org/article/4601032046324b4ca2ee1ab20f0a5052
Autor:
Icro Meattini, Giulio Francolini, Vanessa Di Cataldo, Luca Visani, Carlotta Becherini, Erika Scoccimarro, Viola Salvestrini, Chiara Bellini, Laura Masi, Raffaela Doro, Federica Di Naro, Mauro Loi, Giulia Salvatore, Gabriele Simontacchi, Daniela Greto, Marco Bernini, Jacopo Nori, Lorenzo Orzalesi, Simonetta Bianchi, Monica Mangoni, Lorenzo Livi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 37, Iss , Pp 94-100 (2022)
Background and purpose: Preoperative partial breast irradiation (PBI) has got the advantage of treating a well-defined target. We report the results of the phase II ROCK trial (NCT03520894), enrolling early breast cancer (BC) patients treated with pr
Externí odkaz:
https://doaj.org/article/8f1bd43896684de4ba97c8b20e6dd6fb
Autor:
Ilaria Morelli, Carlotta Becherini, Marco Banini, Marianna Valzano, Niccolò Bertini, Mauro Loi, Giulio Francolini, Icro Meattini, Viola Salvestrini, Pierluigi Bonomo, Lorenzo Livi, Isacco Desideri
Publikováno v:
Applied Sciences, Vol 13, Iss 23, p 12942 (2023)
Background: Oropharyngeal Squamous Cell Carcinoma (OPSCC) is rapidly increasing due to the spread of Human Papillomavirus (HPV) infection. HPV-positive disease has unique characteristics, with better response to treatment and consequent better progno
Externí odkaz:
https://doaj.org/article/e4198cd12a014323a5a9c2d90a673275
Autor:
Viola Salvestrini, Carlotta Becherini, Luca Visani, Isacco Desideri, Ilaria Morelli, Erika Scoccimarro, Cecilia Cerbai, Ilaria Bonaparte, Niccolo Bertini, Beatrice Bettazzi, Vieri Scotti, Marco Bernini, Lorenzo Orzalesi, Jacopo Nori, Simonetta Bianchi, Giulio Francolini, Icro Meattini, Lorenzo Livi
Publikováno v:
Clinical and Experimental Obstetrics & Gynecology, Vol 50, Iss 2, p 41 (2023)
Objectives: In breast cancer (BC) patients receiving mastectomy, postmastectomy radiotherapy (PMRT) improves long-term outcomes by decreasing local failure and cancer mortality. However, the optimal PMRT schedule is still under investigation. The pre
Externí odkaz:
https://doaj.org/article/5032b519725644fba1b0f7451165f7d5
Autor:
Mauro Loi, Giulia Salvatore, Michele Aquilano, Daniela Greto, Cinzia Talamonti, Viola Salvestrini, Maria Elena Melica, Marianna Valzano, Giulio Francolini, Mariangela Sottili, Costanza Santini, Carlotta Becherini, Domenico Andrea Campanacci, Monica Mangoni, Lorenzo Livi
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 14305 (2022)
Trabectedin is used for the treatment of advanced soft tissue sarcomas (STSs). In this study, we evaluated if trabectedin could enhance the efficacy of irradiation (IR) by increasing the intrinsic cell radiosensitivity and modulating tumor micro-envi
Externí odkaz:
https://doaj.org/article/04fbe55788a8433a94004161c664547c
Autor:
Tara Behroozian, Pierluigi Bonomo, Partha Patel, Lauren Kanee, Samuel Finkelstein, Corina van den Hurk, Edward Chow, Julie Ryan Wolf, Suvam Banerjee, Carlotta Becherini, Christine Boers-Doets, Marta Carlesimo, Gemma Caro, Maria Caterina Fortuna, Adrian Wai Chan, Lorraine Drapek, Azael Freites-Martinez, Satoshi Hirakawa, Emily Hoffman Smith, Nicola Alessandro Iacovelli, Bernice Kwong, Shing Fung Lee, Alina Markova, Robert Miller, Gustavo Nader Marta, Silvina Pugliese, Claire Marie Reyes Habito, Jolien Robijns, Viola Salvestrini, Leonard Christopher Schmeel, Mateusz Spalek, Mark Trombetta, Henry Chun Yip Wong
Publikováno v:
The Lancet Oncology. 24:e172-e185
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change
Autor:
Beatrice Detti, Gianluca Ingrosso, Carlotta Becherini, Andrea Lancia, Emanuela Olmetto, Emanuele Alì, Simona Marani, Maria Ausilia Teriaca, Giulio Francolini, Angela Sardaro, Cynthia Aristei, Andrea Riccardo Filippi, Giuseppe Sanguineti, Lorenzo Livi
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100331- (2021)
Purpose: To adapt the management of prostate malignancy in response to the COVID-19 pandemic. Methods: In according to the recommendations of the European Association of Urology, we have developed practical additional document on the treatment of pro
Externí odkaz:
https://doaj.org/article/ea07202e78a04b738b3b92555b493622
Autor:
Isacco Desideri, Mauro Loi, Giulio Francolini, Carlotta Becherini, Lorenzo Livi, Pierluigi Bonomo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Normal tissue complication probability (NTCP) models that were formulated in the Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) are one of the pillars in support of everyday’s clinical radiation oncology. Because of steady t
Externí odkaz:
https://doaj.org/article/f8603462692d409cbd9382139883f15b
Autor:
Gianluca Ingrosso, Marta Bottero, Carlotta Becherini, Saverio Caini, Emanuele Alì, Andrea Lancia, Piet Ost, Giuseppe Sanguineti, Shankar Siva, Thomas Zilli, Giulio Francolini, Rita Bellavita, Cynthia Aristei, Lorenzo Livi, Beatrice Detti
Publikováno v:
Seminars in Oncology. 49:409-418
Prostate cancer is the second most common cause of cancer-related mortality in men. In patients undergoing a failure after radical treatment, one of the therapeutic option is androgen deprivation: despite initial response rates, a progression to a st
Publikováno v:
Current Opinion in Oncology. 34:647-652
The introduction of primary systemic therapy has established a new treatment paradigm for breast cancer patients. However, recommendations for regional node irradiation after neoadjuvant chemotherapy are not supported by level I evidence, yet.In addi